This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.
Device | P030034S016 |
Classification Name | None |
Applicant | |
PMA | P030034 |
Supplement | S016 |
Supplement Number | Date | Supplement Type |
---|---|---|
P030034 | Original Filing | |
S017 | 2022-03-16 | Real-time Process |
S016 | ||
S015 | 2019-09-16 | 30-day Notice |
S014 | 2019-04-15 | Real-time Process |
S013 | 2018-09-27 | Real-time Process |
S012 | 2018-05-24 | Real-time Process |
S011 | 2017-12-07 | Real-time Process |
S010 | 2017-03-24 | Real-time Process |
S009 | 2016-07-05 | Normal 180 Day Track |
S008 | 2015-07-28 | 30-day Notice |
S007 | 2014-08-01 | 30-day Notice |
S006 | 2011-10-03 | 30-day Notice |
S005 | 2011-01-19 | Real-time Process |
S004 | 2010-01-21 | Normal 180 Day Track No User Fee |
S003 | 2009-08-04 | 30-day Notice |
S002 | 2009-05-07 | Real-time Process |
S001 | 2005-02-14 | Real-time Process |
Device ID | PMA | Supp |
---|---|---|
18257200078936 | P030034 | 006 |
18257200007158 | P030034 | 006 |
18257200007165 | P030034 | 006 |
18257200079094 | P030034 | 006 |
18257200079100 | P030034 | 006 |
18257200079131 | P030034 | 006 |
18257200080816 | P030034 | 006 |
18257200080823 | P030034 | 006 |
18257200123919 | P030034 | 009 |
18257200105663 | P030034 | 009 |
18257200123933 | P030034 | 009 |
18257200131440 | P030034 | 009 |
18257200105649 | P030034 | 009 |
18257200105632 | P030034 | 009 |
18257200105656 | P030034 | 009 |